K31.A
Gastric intestinal metaplasia
Clinical Classification Guidelines
Medical Intelligence & Overview
Gastric intestinal metaplasia is a condition where the lining of the stomach changes to resemble that of the intestines. This abnormal transformation often results from chronic inflammation or damage within the stomach lining, typically due to factors like long-term gastritis or Helicobacter pylori infection. While it is considered a precancerous condition, not everyone with this change will develop stomach cancer. Recognizing and understanding this condition can help in monitoring and managing potential risks.
Causes & Symptoms
Clinical Causes: Chronic Helicobacter pylori infection Long-standing gastritis Prolonged use of certain medications such as NSAIDs Autoimmune gastritis Dietary factors, including high salt or smoked foods Lifestyle factors like smoking and excessive alcohol consumption Genetic predispositions
Key Symptoms: Indigestion or heartburn Feelings of bloating or fullness after eating Nausea or discomfort in the upper abdomen Unintentional weight loss in some cases Occasional vomiting, sometimes with blood No noticeable symptoms in early stages
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves endoscopic examination, during which a healthcare provider looks at the stomach lining and takes tissue samples (biopsies). These samples are then examined under a microscope to confirm the presence of intestinal metaplasia. Additional tests such as urea breath tests or stool tests may be performed to identify Helicobacter pylori infection, which is often associated with the condition.
Treatment Protocols: While there is no specific treatment to reverse gastric intestinal metaplasia, managing underlying causes and reducing risk factors are essential. Approaches may include eradication of H. pylori infection with antibiotics, medications to reduce stomach acid, and lifestyle modifications like dietary changes, smoking cessation, and limiting alcohol intake. Regular monitoring and follow-up endoscopies are often recommended to track any progression or development of precancerous changes. In some cases, healthcare providers may advise nutritional support or supplements to promote overall stomach health.
Clinical Advice & FAQs
Billing Guidance
Is K31.A a billable ICD-10 code?
Yes, K31.A is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report K31.A?
Clinical documentation must specify the nature of Gastric intestinal metaplasia and any associated comorbidities for accurate reporting.
Cite this Clinical Reference